【4521】科研製薬

製薬。関節機能改善剤。

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2024.03	2024/02/06	Q3予	73,100	→	0.0%	0.0%	7,600	→	0.0%	0.0%	8,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%
2024.03	2023/11/08	Q2予	73,100	→	0.0%	0.0%	7,600	→	0.0%	0.0%	8,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%
2024.03	2023/08/04	Q1予	73,100	→	0.0%	0.0%	7,600	→	0.0%	0.0%	8,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%
2024.03	2023/05/10	当初予	73,100	-	-	-	7,600	-	-	-	8,000	-	-	-	6,700	-	-	-
2023.03	2023/05/10	実	72,984	↓	-0.7%	-4.5%	7,998	↑	+6.6%	-46.7%	8,727	↑	+7.7%	-43.7%	5,440	↓	-10.8%	-54.7%
2023.03	2023/02/03	Q3予	73,500	↓	-3.8%	-3.8%	7,500	↓	-50.0%	-50.0%	8,100	↓	-47.7%	-47.7%	6,100	↓	-49.2%	-49.2%
2023.03	2022/11/08	Q2予	76,400	→	0.0%	0.0%	15,000	→	0.0%	0.0%	15,500	→	0.0%	0.0%	12,000	→	0.0%	0.0%
2023.03	2022/08/03	Q1予	76,400	→	0.0%	0.0%	15,000	→	0.0%	0.0%	15,500	→	0.0%	0.0%	12,000	→	0.0%	0.0%
2023.03	2022/05/11	当初予	76,400	-	-	-	15,000	-	-	-	15,500	-	-	-	12,000	-	-	-
2022.03	2022/05/11	実	76,034	↑	+0.0%	-4.0%	17,064	↑	+3.4%	-9.2%	17,542	↑	+3.2%	-8.6%	9,549	↑	+3.8%	-31.8%
2022.03	2022/03/29	修正予	76,000	↓	-4.0%	-4.0%	16,500	↓	-12.2%	-12.2%	17,000	↓	-11.5%	-11.5%	9,200	↓	-34.3%	-34.3%
2022.03	2022/02/03	Q3予	79,200	→	0.0%	0.0%	18,800	→	0.0%	0.0%	19,200	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2022.03	2021/11/04	Q2予	79,200	→	0.0%	0.0%	18,800	→	0.0%	0.0%	19,200	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2022.03	2021/08/03	Q1予	79,200	→	0.0%	0.0%	18,800	→	0.0%	0.0%	19,200	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2022.03	2021/05/07	当初予	79,200	-	-	-	18,800	-	-	-	19,200	-	-	-	14,000	-	-	-
2021.03	2021/05/07	実	74,979	↓	-2.9%	-9.6%	17,788	↓	-1.7%	-14.5%	18,222	↓	-1.5%	-14.0%	13,405	↑	+0.0%	-10.6%
2021.03	2021/02/03	Q3予	77,200	→	0.0%	-6.9%	18,100	→	0.0%	-13.0%	18,500	→	0.0%	-12.7%	13,400	→	0.0%	-10.7%
2021.03	2020/11/05	Q2予	77,200	→	0.0%	-6.9%	18,100	→	0.0%	-13.0%	18,500	→	0.0%	-12.7%	13,400	→	0.0%	-10.7%
2021.03	2020/10/27	修正予	77,200	↓	-6.9%	-6.9%	18,100	↓	-13.0%	-13.0%	18,500	↓	-12.7%	-12.7%	13,400	↓	-10.7%	-10.7%
2021.03	2020/08/03	修正予	82,900	-	-	-	20,800	-	-	-	21,200	-	-	-	15,000	-	-	-
2020.03	2020/03/27	修正予	89,000	↓	-4.2%	-4.2%	26,000	↑	+16.6%	+16.6%	26,400	↑	+16.3%	+16.3%	18,600	↑	+15.5%	+15.5%
2020.03	2020/02/03	Q3予	92,900	→	0.0%	0.0%	22,300	→	0.0%	0.0%	22,700	→	0.0%	0.0%	16,100	→	0.0%	0.0%
2020.03	2019/11/06	Q2予	92,900	→	0.0%	0.0%	22,300	→	0.0%	0.0%	22,700	→	0.0%	0.0%	16,100	→	0.0%	0.0%
2020.03	2019/08/01	Q1予	92,900	→	0.0%	0.0%	22,300	→	0.0%	0.0%	22,700	→	0.0%	0.0%	16,100	→	0.0%	0.0%
2020.03	2019/05/09	当初予	92,900	-	-	-	22,300	-	-	-	22,700	-	-	-	16,100	-	-	-
2019.03	2019/05/09	実	94,165	↓	-0.7%	-0.7%	24,592	↑	+9.3%	+9.3%	24,972	↑	+9.5%	+9.5%	17,775	↑	+8.4%	+8.4%
2019.03	2019/02/01	Q3予	94,800	→	0.0%	0.0%	22,500	→	0.0%	0.0%	22,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%
2019.03	2018/11/06	Q2予	94,800	→	0.0%	0.0%	22,500	→	0.0%	0.0%	22,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%
2019.03	2018/08/01	Q1予	94,800	→	0.0%	0.0%	22,500	-	-	-	22,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%
2019.03	2018/05/09	当初予	94,800	-	-	-	-	-	-	-	22,800	-	-	-	16,400	-	-	-
2018.03	2018/05/09	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.03	2018/02/01	Q3予	101,700	→	0.0%	0.0%	26,800	→	0.0%	0.0%	27,000	→	0.0%	0.0%	19,100	→	0.0%	0.0%
2018.03	2017/11/06	Q2予	101,700	→	0.0%	0.0%	26,800	→	0.0%	0.0%	27,000	→	0.0%	0.0%	19,100	→	0.0%	0.0%
2018.03	2017/08/01	Q1予	101,700	→	0.0%	0.0%	26,800	→	0.0%	0.0%	27,000	→	0.0%	0.0%	19,100	→	0.0%	0.0%
2018.03	2017/05/10	当初予	101,700	-	-	-	26,800	-	-	-	27,000	-	-	-	19,100	-	-	-
2017.03	2017/05/10	実	101,479	↑	+0.2%	-4.4%	30,707	↑	+0.3%	+6.3%	30,981	↑	+0.3%	+6.5%	22,017	↑	+1.0%	+5.9%
2017.03	2017/03/28	修正予	101,300	↓	-4.5%	-4.5%	30,600	↑	+5.9%	+5.9%	30,900	↑	+6.2%	+6.2%	21,800	↑	+4.8%	+4.8%
2017.03	2017/02/06	Q3予	106,100	→	0.0%	0.0%	28,900	→	0.0%	0.0%	29,100	→	0.0%	0.0%	20,800	→	0.0%	0.0%
2017.03	2016/11/07	Q2予	106,100	→	0.0%	0.0%	28,900	→	0.0%	0.0%	29,100	→	0.0%	0.0%	20,800	→	0.0%	0.0%
2017.03	2016/08/03	Q1予	106,100	→	0.0%	0.0%	28,900	→	0.0%	0.0%	29,100	→	0.0%	0.0%	20,800	→	0.0%	0.0%
2017.03	2016/05/12	当初予	106,100	-	-	-	28,900	-	-	-	29,100	-	-	-	20,800	-	-	-
2016.03	2016/05/12	実	109,730	↑	+1.7%	+11.4%	35,146	↑	+9.1%	+67.4%	35,365	↑	+9.2%	+67.6%	21,143	↑	+10.1%	+51.0%
2016.03	2016/02/05	Q3予	107,900	→	0.0%	+9.5%	32,200	→	0.0%	+53.3%	32,400	→	0.0%	+53.6%	19,200	→	0.0%	+37.1%
2016.03	2015/11/06	Q2予	107,900	→	0.0%	+9.5%	32,200	→	0.0%	+53.3%	32,400	→	0.0%	+53.6%	19,200	→	0.0%	+37.1%
2016.03	2015/10/27	修正予	107,900	↑	+9.5%	+9.5%	32,200	↑	+53.3%	+53.3%	32,400	↑	+53.6%	+53.6%	19,200	↑	+37.1%	+37.1%
2016.03	2015/08/05	Q1予	98,500	→	0.0%	0.0%	21,000	→	0.0%	0.0%	21,100	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2016.03	2015/05/12	当初予	98,500	-	-	-	21,000	-	-	-	21,100	-	-	-	14,000	-	-	-
2015.03	2015/05/12	実	93,889	↓	-0.0%	+2.7%	20,631	↑	+0.2%	+22.8%	20,394	↑	+0.5%	+24.4%	12,122	↑	+2.7%	+13.3%
2015.03	2015/03/26	修正予	93,900	↑	+2.7%	+2.7%	20,600	↑	+22.6%	+22.6%	20,300	↑	+23.8%	+23.8%	11,800	↑	+10.3%	+10.3%
2015.03	2015/02/05	Q3予	91,400	→	0.0%	0.0%	16,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%	10,700	→	0.0%	0.0%
2015.03	2014/11/06	Q2予	91,400	→	0.0%	0.0%	16,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%	10,700	→	0.0%	0.0%
2015.03	2014/08/05	Q1予	91,400	→	0.0%	0.0%	16,800	→	0.0%	0.0%	16,400	→	0.0%	0.0%	10,700	→	0.0%	0.0%
2015.03	2014/05/12	当初予	91,400	-	-	-	16,800	-	-	-	16,400	-	-	-	10,700	-	-	-
2014.03	2014/05/12	実	88,946	-	-	-	15,872	-	-	-	15,521	-	-	-	9,735	-	-	-

【4521】科研製薬 製薬。関節機能改善剤。

業績予想修正履歴

【4521】科研製薬

製薬。関節機能改善剤。